| Literature DB >> 31094704 |
Shaikh M Atif1, Douglas G Mack1, Amy S McKee1, Javier Rangel-Moreno2, Allison K Martin1, Andrew Getahun3, Lisa A Maier1,4, John C Cambier3, Rubin Tuder1, Andrew P Fontenot1,3.
Abstract
Susceptibility to chronic beryllium (Be) disease is linked to HLA-DP molecules possessing a glutamic acid at the 69th position of the β-chain (βGlu69), with the most prevalent βGlu69-containing molecule being HLA-DP2. We have previously shown that HLA-DP2 transgenic (Tg) mice exposed to Be oxide (BeO) develop mononuclear infiltrates in a peribronchovascular distribution and a beryllium-specific, HLA-DP2-restricted CD4+ T cell response. In addition to T cells, B cells constituted a major portion of infiltrated leukocytes in the lung of BeO-exposed HLA-DP2 Tg mice and sequester BeO particles within ectopic lymphoid aggregates and granulomas. B cell depletion was associated with a loss of lymphoid aggregates and granulomas as well as a significant increase in lung injury in BeO-exposed mice. The protective role of B cells was innate in origin, and BeO-induced B cell recruitment to the lung was dependent on MyD88 signaling. Similar to BeO-exposed HLA-DP2 mice, B cells also accumulate in the lungs of CBD subjects, located at the periphery and surrounding the granuloma. Overall, our data suggest a novel modulatory role for B cells in the protection of the lung against sterile particulate exposure, with B cell recruitment to the inflamed lung occurring in an antigen-independent and MyD88-dependent manner.Entities:
Keywords: Adaptive immunity; B cells; Chemokines; Immunology; Pulmonology
Year: 2019 PMID: 31094704 PMCID: PMC6629102 DOI: 10.1172/jci.insight.125494
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708